Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
33.61
+0.63 (1.91%)
At close: Mar 9, 2026, 4:00 PM EDT
33.50
-0.11 (-0.33%)
After-hours: Mar 9, 2026, 5:52 PM EDT
Viking Therapeutics Employees
Viking Therapeutics had 53 employees as of December 31, 2025. The number of employees increased by 17 or 47.22% compared to the previous year.
Employees
53
Change (1Y)
17
Growth (1Y)
47.22%
Revenue / Employee
n/a
Profits / Employee
-$6,785,642
Market Cap
3.88B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,609 |
| ACADIA Pharmaceuticals | 798 |
| Corcept Therapeutics | 730 |
| ADMA Biologics | 685 |
| Crinetics Pharmaceuticals | 594 |
| TG Therapeutics | 374 |
| Xenon Pharmaceuticals | 370 |
| Structure Therapeutics | 220 |
VKTX News
- 4 days ago - Viking Therapeutics to Participate at Upcoming Investor Conferences - PRNewsWire
- 14 days ago - Viking Therapeutics Stock Gains Amid Obesity Drug Buzz - Benzinga
- 23 days ago - Viking Therapeutics: Full-Speed Ahead - Seeking Alpha
- 24 days ago - Viking Therapeutics: Buyers Are Quietly Accumulating On Its Obesity Drugs Launch Potential - Seeking Alpha
- 25 days ago - Viking Therapeutics, Inc. (VKTX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Viking Therapeutics plans to advance oral obesity drug to late-stage trial - Reuters
- 26 days ago - Viking Therapeutics Stock Climbs After Q4 Report: Details - Benzinga
- 26 days ago - Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update - PRNewsWire